How many studies have been conducted on Glatiramer Acetate?

BiohacksAI has indexed 293 PubMed studies on Glatiramer Acetate, including 19 randomized controlled trials (RCTs). 55% of studies involve human subjects.

What are the main research areas for Glatiramer Acetate?

The primary research domains for Glatiramer Acetate are 🛡️ Immunity, 😴 Sleep, ⏳ Longevity & Aging. This is based on analysis of 293 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Glatiramer Acetate

A random polymer of L-ALANINE, L-GLUTAMIC ACID, L-LYSINE, and L-TYROSINE that structurally resembles MYELIN BASIC PROTEIN. It is used in the treatment of RELAPSING-REMITTING MULTIPLE SCLEROSIS.

293+ PubMed studies analyzed · 19 RCTs · Evidence Score: 49.3

Research Domains

Glatiramer Acetate has been studied across 19 research domains including 🛡️ Immunity, 😴 Sleep, ⏳ Longevity & Aging, 🔬 Inflammation, 🔬 Oncology. The primary research focus is 🛡️ Immunity with 62% of studies addressing this area.

Loading evidence profile...

This evidence profile for Glatiramer Acetate is generated deterministically from 293 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.